Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-03

Clinical Trial Update: Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cyclophosphamide and prednisone with or without immunoglobulin for abnormal muscle movements in children with neuroblastoma; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Immunoglobulin (immunoglobulin)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: Children's Oncology Group | Conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma | Phase 3 | Status: COMPLETED | Results posted: 2016-10-03